Literature DB >> 21389131

UL31 of herpes simplex virus 1 is necessary for optimal NF-kappaB activation and expression of viral gene products.

Kari L Roberts1, Joel D Baines.   

Abstract

Previous results suggested that the U(L)31 gene of herpes simplex virus 1 (HSV-1) is required for envelopment of nucleocapsids at the inner nuclear membrane and optimal viral DNA synthesis and DNA packaging. In the current study, viral gene expression and NF-κB and c-Jun N-terminal kinase (JNK) activation of a herpes simplex virus mutant lacking the U(L)31 gene, designated ΔU(L)31, and its genetic repair construct, designated ΔU(L)31-R, were studied in various cell lines. In Hep2 and Vero cells infected with ΔU(L)31, expression of the immediate-early protein ICP4, early protein ICP8, and late protein glycoprotein C (gC) were delayed significantly. In Hep2 cells, expression of these proteins failed to reach levels seen in cells infected with ΔU(L)31-R or wild-type HSV-1(F) even after 18 h. The defect in protein accumulation correlated with poor or no activation of NF-κB and JNK upon infection with ΔU(L)31 compared to wild-type virus infection. The protein expression defects of the U(L)31 deletion mutant were not explainable by a failure to enter nonpermissive cells and were not complemented in an ICP27-expressing cell line. These data suggest that pU(L)31 facilitates initiation of infection and/or accelerates the onset of viral gene expression in a manner that correlates with NF-κB activation and is independent of the transactivator ICP27. The effects on very early events in expression are surprising in light of the fact that U(L)31 is designated a late gene and pU(L)31 is not a virion component. We show herein that while most pUL31 is expressed late in infection, low levels of pU(L)31 are detectable as early as 2 h postinfection, consistent with an early role in HSV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21389131      PMCID: PMC3126170          DOI: 10.1128/JVI.00068-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Herpes simplex virus type 1 U(L)34 gene product is required for viral envelopment.

Authors:  R J Roller; Y Zhou; R Schnetzer; J Ferguson; D DeSalvo
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 2.  Hostile takeovers: viral appropriation of the NF-kappaB pathway.

Authors:  J Hiscott; H Kwon; P Génin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

3.  Ultrastructural localization of the herpes simplex virus type 1 UL31, UL34, and US3 proteins suggests specific roles in primary envelopment and egress of nucleocapsids.

Authors:  Ashley E Reynolds; Elizabeth G Wills; Richard J Roller; Brent J Ryckman; Joel D Baines
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 4.  Signaling to NF-kappaB.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2004-09-15       Impact factor: 11.361

5.  Comprehensive characterization of extracellular herpes simplex virus type 1 virions.

Authors:  Sandra Loret; Ginette Guay; Roger Lippé
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

6.  The interacting UL31 and UL34 gene products of pseudorabies virus are involved in egress from the host-cell nucleus and represent components of primary enveloped but not mature virions.

Authors:  Walter Fuchs; Barbara G Klupp; Harald Granzow; Nikolaus Osterrieder; Thomas C Mettenleiter
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  U(L)31 and U(L)34 proteins of herpes simplex virus type 1 form a complex that accumulates at the nuclear rim and is required for envelopment of nucleocapsids.

Authors:  A E Reynolds; B J Ryckman; J D Baines; Y Zhou; L Liang; R J Roller
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

8.  Activation of I kappa b kinase by herpes simplex virus type 1. A novel target for anti-herpetic therapy.

Authors:  C Amici; G Belardo; A Rossi; M G Santoro
Journal:  J Biol Chem       Date:  2001-05-31       Impact factor: 5.157

9.  Conformational changes in the nuclear lamina induced by herpes simplex virus type 1 require genes U(L)31 and U(L)34.

Authors:  Ashley E Reynolds; Li Liang; Joel D Baines
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  Cell lines that support replication of a novel herpes simplex virus 1 UL31 deletion mutant can properly target UL34 protein to the nuclear rim in the absence of UL31.

Authors:  Li Liang; Michiko Tanaka; Yasushi Kawaguchi; Joel D Baines
Journal:  Virology       Date:  2004-11-10       Impact factor: 3.616

View more
  15 in total

1.  Association of herpes simplex virus pUL31 with capsid vertices and components of the capsid vertex-specific complex.

Authors:  Kui Yang; Elizabeth Wills; Han Young Lim; Z Hong Zhou; Joel D Baines
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

2.  Herpes Simplex Virus 1 Dramatically Alters Loading and Positioning of RNA Polymerase II on Host Genes Early in Infection.

Authors:  Claire H Birkenheuer; Charles G Danko; Joel D Baines
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

3.  Herpes simplex virus glycoproteins gH/gL and gB bind Toll-like receptor 2, and soluble gH/gL is sufficient to activate NF-κB.

Authors:  Valerio Leoni; Tatiana Gianni; Stefano Salvioli; Gabriella Campadelli-Fiume
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

4.  HSV-1\EGFP stimulates miR-146a expression in a NF-κB-dependent manner in monocytic THP-1 cells.

Authors:  Assunta Venuti; Maria Musarra-Pizzo; Rosamaria Pennisi; Stoyan Tankov; Maria Antonietta Medici; Antonio Mastino; Ana Rebane; Maria Teresa Sciortino
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

5.  Oligonucleotides designed to inhibit TLR9 block Herpes simplex virus type 1 infection at multiple steps.

Authors:  Monica M Sauter; Joshua J L Gauger; Curtis R Brandt
Journal:  Antiviral Res       Date:  2014-07-01       Impact factor: 5.970

6.  Concurrent chemotherapy inhibits herpes simplex virus-1 replication and oncolysis.

Authors:  Y Kulu; H Kawasaki; J M Donahue; H Kasuya; J C Cusack; E W Choi; D K Kuruppu; B C Fuchs; K K Tanabe
Journal:  Cancer Gene Ther       Date:  2013-01-25       Impact factor: 5.987

7.  Herpes simplex virus 1 E3 ubiquitin ligase ICP0 protein inhibits tumor necrosis factor alpha-induced NF-κB activation by interacting with p65/RelA and p50/NF-κB1.

Authors:  Jie Zhang; Kezhen Wang; Shuai Wang; Chunfu Zheng
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

8.  Herpes simplex virus 1 DNA polymerase processivity factor UL42 inhibits TNF-α-induced NF-κB activation by interacting with p65/RelA and p50/NF-κB1.

Authors:  Jie Zhang; Shuai Wang; Kezhen Wang; Chunfu Zheng
Journal:  Med Microbiol Immunol       Date:  2013-05-01       Impact factor: 3.402

9.  The epithelial αvβ3-integrin boosts the MYD88-dependent TLR2 signaling in response to viral and bacterial components.

Authors:  Tatiana Gianni; Gabriella Campadelli-Fiume
Journal:  PLoS Pathog       Date:  2014-11-06       Impact factor: 6.823

10.  Herpesvirus entry mediator on radiation-resistant cell lineages promotes ocular herpes simplex virus 1 pathogenesis in an entry-independent manner.

Authors:  Rebecca G Edwards; Sarah J Kopp; Andrew H Karaba; Douglas R Wilcox; Richard Longnecker
Journal:  mBio       Date:  2015-10-20       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.